FAP and heart failure: This delivery system efficiently converted circulating T cells into FAP‐CAR‐Ts in a mouse model of heart failure, and FAP‐CAR‐Ts eliminated activated fibroblasts in a dose‐dependent manner similar to their virally engineered counterparts, alleviating fibrosis and restoring cardiac function after injury.